HK1091894A1 - Prion protein binding materials and methods of use - Google Patents

Prion protein binding materials and methods of use

Info

Publication number
HK1091894A1
HK1091894A1 HK06108070A HK06108070A HK1091894A1 HK 1091894 A1 HK1091894 A1 HK 1091894A1 HK 06108070 A HK06108070 A HK 06108070A HK 06108070 A HK06108070 A HK 06108070A HK 1091894 A1 HK1091894 A1 HK 1091894A1
Authority
HK
Hong Kong
Prior art keywords
methods
protein binding
prion protein
binding materials
materials
Prior art date
Application number
HK06108070A
Other languages
English (en)
Inventor
Steven J Burton
David J Hammond
Ruben G Carbonell
Honglue Shen
Patrick V Gurgel
Viterose Wiltshire-Lyerly
Original Assignee
Pathogen Removal & Diagnostic Technologies Inc
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathogen Removal & Diagnostic Technologies Inc, Univ North Carolina State filed Critical Pathogen Removal & Diagnostic Technologies Inc
Publication of HK1091894A1 publication Critical patent/HK1091894A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK06108070A 2003-04-04 2006-07-18 Prion protein binding materials and methods of use HK1091894A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46047403P 2003-04-04 2003-04-04
PCT/US2004/010315 WO2004090102A2 (en) 2003-04-04 2004-04-02 Prion protein binding materials and methods of use

Publications (1)

Publication Number Publication Date
HK1091894A1 true HK1091894A1 (en) 2007-01-26

Family

ID=33159772

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06108070A HK1091894A1 (en) 2003-04-04 2006-07-18 Prion protein binding materials and methods of use

Country Status (16)

Country Link
US (1) US7393658B2 (xx)
EP (1) EP1615992B1 (xx)
JP (1) JP4783727B2 (xx)
CN (1) CN1842707B (xx)
AU (1) AU2004227389B2 (xx)
CA (1) CA2521438C (xx)
DK (1) DK1615992T3 (xx)
EG (1) EG26681A (xx)
ES (1) ES2436638T3 (xx)
HK (1) HK1091894A1 (xx)
IL (1) IL171279A (xx)
NZ (1) NZ543371A (xx)
PL (1) PL1615992T3 (xx)
PT (1) PT1615992E (xx)
SG (1) SG187269A1 (xx)
WO (1) WO2004090102A2 (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953551B1 (en) * 2002-12-03 2014-02-19 Pathogen Removal and Diagnostic Technologies, Inc. Prion protein ligands and methods of use
JP4428616B2 (ja) * 2003-05-06 2010-03-10 オルガノ株式会社 グラフト修飾有機多孔質体及びその製造方法並びに吸着剤、クロマトグラフィー用充填剤及びイオン交換体
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US7439041B2 (en) 2003-08-13 2008-10-21 Novartis Vaccines And Diagnostics, Inc. Prion-specific peptide reagents
US20050054003A1 (en) * 2003-09-10 2005-03-10 Stenland Christopher J. Prion clearance using particulate metal oxides
AP2006003861A0 (en) * 2004-06-09 2006-12-31 Pathogen Removal And Diagnosti Particles embedded in a porous substrate for removing target analyte from a sample
WO2006076687A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Elisa assays using prion-specific peptide reagents
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
WO2007030804A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
FR2891747B1 (fr) 2005-10-10 2007-12-14 Maco Pharma Sa Unite de filtration pour l'elimination selective d'une substance cible
EP2036584B1 (en) * 2006-06-27 2015-01-21 Asahi Kasei Kabushiki Kaisha Substrate for biological fluid treatment
RU2410128C2 (ru) * 2006-07-12 2011-01-27 Асахи Касеи Медикал Ко., Лтд. Способ удаления патологического прионного белка из продуктов крови
AU2009243060A1 (en) * 2008-04-30 2009-11-05 Novartis Ag. Assay for pathogenic conformers
ME03596B (me) 2009-04-15 2020-07-20 Abraxis Bioscience Llc Kompozicije nanočesтica bez priona i postupci povezani sa njima
PL221899B1 (pl) * 2011-05-06 2016-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Czysta albumina oraz sposób jej otrzymywania i detekcji
FR2983735B1 (fr) * 2011-12-13 2019-12-13 Maco Pharma Nouvelle utilisation d'un materiau capable de lier la proteine prion
CN113376364A (zh) 2015-08-10 2021-09-10 Essenlix 公司 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法
AU2016323062A1 (en) 2015-09-14 2018-04-12 Essenlix Corp. Device and system for analyzing a sample, particularly blood, as well as methods of using the same
AU2016323072B2 (en) 2015-09-14 2019-09-19 Essenlix Corporation Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same
JP6667052B1 (ja) 2016-12-21 2020-03-18 エッセンリックス コーポレーション 試料を認証するためのデバイスおよび方法ならびにその使用
EP3579981A4 (en) 2017-02-07 2021-03-31 Essenlix Corporation COMPRESSED OPEN FLOW TEST AND USE
WO2018148470A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
US11927560B2 (en) 2017-02-08 2024-03-12 Essenlix Corporation Bio/chemical material extraction and assay
EP3580565B1 (en) 2017-02-09 2024-05-29 Essenlix Corporation Assay using different spacing heights
CA3053120A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Colorimetric assays
US11940382B2 (en) 2017-02-09 2024-03-26 Essenlix Corporation Assay with amplification
US10966634B2 (en) 2017-02-16 2021-04-06 Essenlix Corporation Assay with textured surface
CN111492222A (zh) 2017-08-01 2020-08-04 Essenlix公司 样品收集、保持和测定
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
CN112689758A (zh) 2017-08-01 2021-04-20 Essenlix公司 检查药物对微生物影响的装置和方法
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
CN112534259A (zh) 2017-12-14 2021-03-19 Essenlix公司 监测毛发的装置，系统和方法
US11156606B2 (en) 2018-01-11 2021-10-26 Essenlix Corporation Homogeneous assay (II)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133866A (en) 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
WO1991005262A1 (en) 1989-10-02 1991-04-18 University Of Michigan Bioanalytical detection system
US5498538A (en) 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
DE69228701T2 (de) 1991-12-03 1999-07-29 Proteus Molecular Design Ltd., Macclesfield, Cheshire Fragmente von Prion Proteinen.
US5312730A (en) 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
JPH08178926A (ja) 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5834318A (en) 1995-05-10 1998-11-10 Bayer Corporation Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
US5750361A (en) 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
US5808011A (en) 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6750025B1 (en) * 1998-07-09 2004-06-15 V.I. Technologies, Inc. Method of detecting and isolating prion protein and variants thereof
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
EP1272509A2 (en) * 2000-04-05 2003-01-08 V.I. Technologies, Inc. Prion-binding peptidic ligands and methods of using same
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
US7022486B2 (en) 2001-08-13 2006-04-04 Douglas A. Campbell Peptide sequence tags and method of using same
DE10152677A1 (de) 2001-10-19 2003-05-08 Aventis Behring Gmbh Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführten Nachweisverfahren

Also Published As

Publication number Publication date
US20050014196A1 (en) 2005-01-20
WO2004090102A2 (en) 2004-10-21
EP1615992A4 (en) 2007-11-07
PT1615992E (pt) 2013-11-29
ES2436638T3 (es) 2014-01-03
NZ543371A (en) 2008-04-30
US7393658B2 (en) 2008-07-01
CN1842707B (zh) 2012-06-27
EP1615992A2 (en) 2006-01-18
WO2004090102A3 (en) 2006-03-16
EG26681A (en) 2014-06-01
AU2004227389A1 (en) 2004-10-21
IL171279A (en) 2014-01-30
AU2004227389B2 (en) 2010-09-16
CN1842707A (zh) 2006-10-04
SG187269A1 (en) 2013-02-28
JP4783727B2 (ja) 2011-09-28
EP1615992B1 (en) 2013-08-28
PL1615992T3 (pl) 2014-03-31
JP2006522344A (ja) 2006-09-28
DK1615992T3 (da) 2013-12-09
CA2521438C (en) 2014-03-25
CA2521438A1 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
HK1091894A1 (en) Prion protein binding materials and methods of use
AP2007003974A0 (en) Prion protein binding materials and methods of use
EP1660013A4 (en) BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
ZA200601653B (en) Binding constructs and methods for use thereof
IL169638A0 (en) Soluble fcyr fusion proteins and methods of use thereof
EP1482984A4 (en) REPLACEMENT ANTIBODIES AND METHOD FOR THEIR MANUFACTURE AND USE
EP1501514A4 (en) PROTEIN-KINASE MODULATORS AND METHODS OF USE
EP1736541A4 (en) NEW GALECTIN 9 MODIFICATION PROTEIN AND ITS USE
EP1794589A4 (en) PROTEIN ARRAYS AND METHOD OF USE THEREOF
AU2003265522A1 (en) FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
EP1767634A4 (en) NEW GALECTIN 8 MODIFICATION PROTEIN AND USE THEREOF
EP1699485A4 (en) ANTI-HYDROLYSATE ANTIBODIES AND ITS USES
IL182749A0 (en) Vwfa and/or ant_ig domain containing proteins
IL172510A0 (en) Antibodies and uses thereof
GB0323238D0 (en) Synthetic LG binding domains of protein L
EP1589033A4 (en) ANTIBODY AND ITS USE
GB0309064D0 (en) Modified peptides and their uses
HK1209050A1 (en) Survivin-derived peptides and use thereof
EP1633850A4 (en) OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE
GB0416699D0 (en) Prion protein ligands and methods of use
AU2003261362A8 (en) Lipid binding molecules and methods of use
EP1577322A4 (en) NEW PROTEINS AND THEIR USE
EP1541677A4 (en) NEW PROTEINS AND USE THEREOF
AU2003296232A1 (en) A human liver regeneration associated protein and the use of it
EP1379548A4 (en) NEW BINDING INTERACTIONS OF THE RGS9 PROTEIN AND METHOD OF USE THEREOF

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240329